Bioconjugates of Chelators with Peptides and Proteins in Nuclear Medicine: Historical Importance, Current Innovations and Future Challenges.
Sign Up to like & getrecommendations! Published in 2020 at "Bioconjugate chemistry"
DOI: 10.1021/acs.bioconjchem.0c00015
Abstract: Molecular radiopharmaceuticals based on bioconjugates of chelators with peptides and proteins have had significant clinical impact in diagnosis and treatment of several types of cancers. In the 1990s, indium-111 and yttrium-90 labelled chelator-peptide/protein conjugates established… read more here.
Keywords: medicine; nuclear medicine; bioconjugates chelators; peptides proteins ... See more keywords